Radiopharm Theranostics Limited (RADX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Radiopharm Theranostics L...

NASDAQ: RADX · Real-Time Price · USD
6.20
0.14 (2.31%)
At close: Oct 03, 2025, 3:55 PM
6.29
1.45%
After-hours: Oct 03, 2025, 05:41 PM EDT

Radiopharm Theranostics Balance Sheet Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
Cash & Equivalents
29.12M 18.58M 11.7M 26.98M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a 40K n/a n/a
Other Long-Term Assets
n/a n/a 40K 40K
Receivables
10.4M 987.41K 4.47M 56.48K
Inventory
n/a n/a n/a n/a
Other Current Assets
337.09K 3.29M 133.13K 228.82K
Total Current Assets
39.85M 22.85M 16.3M 27.26M
Property-Plant & Equipment
53.47K 60.8K 68.33K 1.58K
Goodwill & Intangibles
46.57M 49.09M 58.54M 56.08M
Total Long-Term Assets
46.63M 49.19M 58.65M 56.12M
Total Assets
86.48M 72.04M 74.95M 83.38M
Account Payables
6.35M 6.43M 2.96M 1.19M
Deferred Revenue
1.72M n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
3.87M 6.72M 8.11M 5.73M
Total Current Liabilities
14.93M 17.58M 13.23M 7.88M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
28.68M 27.11M 16.14M 12.54M
Total Long-Term Liabilities
28.68M 27.11M 16.14M 12.54M
Total Liabilities
43.61M 44.68M 29.37M 20.42M
Total Debt
n/a n/a n/a n/a
Book Value
42.87M 27.35M 45.58M 62.96M
Book Value Per Share
6.18 21.23 44.71 61.76
Common Stock
176.56M 100.68M 97.23M 86.76M
Retained Earnings
-145.73M -111.34M -65.35M -30.82M
Comprehensive Income
13.12M 37.93M 10.36M 7.03M
Shareholders Equity
44.79M 28.12M 44.38M 62.96M
Total Investments
n/a 40K n/a n/a